Document is current
Any future updates will be listed below
-
Authors
Shen, Fei http://orcid.org/0000-0003-1545-0955
Jiang, Guanglong http://orcid.org/0000-0002-9233-052X
Philips, Santosh
Cantor, Erica
Gardner, Laura
Xue, Gloria
Cunningham, Geneva
Kassem, Nawal
O’Neill, Anne
Cameron, David
Suter, Thomas M.
Miller, Kathy D. http://orcid.org/0000-0002-7125-883X
Sledge, George W.
Schneider, Bryan P. http://orcid.org/0000-0003-1868-7739
-
Funding
Funding for this research was provided by:
Susan G. Komen for the Cure, Komen Wyoming Affiliate (SAC110056)
Vera Bradley Foundation for Breast Cancer (BPS)
- License Information
-
More Information
Article History
Received: 8 October 2023
Revised: 23 January 2024
Accepted: 26 January 2024
First Online: 12 February 2024
Competing interests
: BPS has received research support from Roche/Genentech for drug supply. The remaining authors declare no competing financial interests.
: This study involves secondary research of coded biological samples and clinical data for which patient consent was not required. It was determined exempt from Institutional Review Board (IRB) review as described in 45CFR 46.104 from the Indiana University IRB (application# 1311859668).
